A Novel PDE10A Inhibitor for Tourette Syndrome and Other Movement Disorders.
Randall D MarshallFrank S MennitiMark A TepperPublished in: Cells (2024)
The preclinical and clinical data presented here support the study of EM-221 in phase 2 trials of Tourette syndrome and other movement disorders.